×
S&P 500   3,824.22 (-0.03%)
DOW   30,917.97 (-0.58%)
QQQ   286.37 (+1.50%)
AAPL   141.17 (+1.61%)
MSFT   262.28 (+1.04%)
META   167.44 (+4.63%)
GOOGL   2,257.86 (+3.82%)
AMZN   113.64 (+3.72%)
TSLA   695.16 (+1.96%)
NVDA   148.88 (+2.51%)
NIO   22.07 (+3.32%)
BABA   119.11 (+2.68%)
AMD   74.73 (+1.44%)
MU   56.62 (+5.54%)
CGC   2.67 (-4.98%)
T   21.15 (-0.75%)
GE   61.84 (-2.68%)
F   11.10 (-1.94%)
DIS   97.00 (+0.89%)
AMC   12.68 (-6.28%)
PFE   51.60 (-1.36%)
PYPL   74.33 (+4.10%)
NFLX   185.07 (+2.85%)
S&P 500   3,824.22 (-0.03%)
DOW   30,917.97 (-0.58%)
QQQ   286.37 (+1.50%)
AAPL   141.17 (+1.61%)
MSFT   262.28 (+1.04%)
META   167.44 (+4.63%)
GOOGL   2,257.86 (+3.82%)
AMZN   113.64 (+3.72%)
TSLA   695.16 (+1.96%)
NVDA   148.88 (+2.51%)
NIO   22.07 (+3.32%)
BABA   119.11 (+2.68%)
AMD   74.73 (+1.44%)
MU   56.62 (+5.54%)
CGC   2.67 (-4.98%)
T   21.15 (-0.75%)
GE   61.84 (-2.68%)
F   11.10 (-1.94%)
DIS   97.00 (+0.89%)
AMC   12.68 (-6.28%)
PFE   51.60 (-1.36%)
PYPL   74.33 (+4.10%)
NFLX   185.07 (+2.85%)
S&P 500   3,824.22 (-0.03%)
DOW   30,917.97 (-0.58%)
QQQ   286.37 (+1.50%)
AAPL   141.17 (+1.61%)
MSFT   262.28 (+1.04%)
META   167.44 (+4.63%)
GOOGL   2,257.86 (+3.82%)
AMZN   113.64 (+3.72%)
TSLA   695.16 (+1.96%)
NVDA   148.88 (+2.51%)
NIO   22.07 (+3.32%)
BABA   119.11 (+2.68%)
AMD   74.73 (+1.44%)
MU   56.62 (+5.54%)
CGC   2.67 (-4.98%)
T   21.15 (-0.75%)
GE   61.84 (-2.68%)
F   11.10 (-1.94%)
DIS   97.00 (+0.89%)
AMC   12.68 (-6.28%)
PFE   51.60 (-1.36%)
PYPL   74.33 (+4.10%)
NFLX   185.07 (+2.85%)
S&P 500   3,824.22 (-0.03%)
DOW   30,917.97 (-0.58%)
QQQ   286.37 (+1.50%)
AAPL   141.17 (+1.61%)
MSFT   262.28 (+1.04%)
META   167.44 (+4.63%)
GOOGL   2,257.86 (+3.82%)
AMZN   113.64 (+3.72%)
TSLA   695.16 (+1.96%)
NVDA   148.88 (+2.51%)
NIO   22.07 (+3.32%)
BABA   119.11 (+2.68%)
AMD   74.73 (+1.44%)
MU   56.62 (+5.54%)
CGC   2.67 (-4.98%)
T   21.15 (-0.75%)
GE   61.84 (-2.68%)
F   11.10 (-1.94%)
DIS   97.00 (+0.89%)
AMC   12.68 (-6.28%)
PFE   51.60 (-1.36%)
PYPL   74.33 (+4.10%)
NFLX   185.07 (+2.85%)
NASDAQ:HQY

HealthEquity Stock Forecast, Price & News

$57.96
+0.29 (+0.50%)
(As of 07/5/2022 03:28 PM ET)
Add
Compare
Today's Range
$54.88
$58.30
50-Day Range
$54.14
$69.01
52-Week Range
$36.81
$82.71
Volume
30,984 shs
Average Volume
984,555 shs
Market Capitalization
$4.89 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$75.73

HealthEquity MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
32.5% Upside
$75.73 Price Target
Short Interest
Bearish
5.08% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.37mentions of HealthEquity in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$94,965 Sold Last Quarter
Proj. Earnings Growth
46.97%
From $0.66 to $0.97 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.16 out of 5 stars

Medical Sector

309th out of 1,428 stocks

Business Services, Not Elsewhere Classified Industry

29th out of 146 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive HQY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.

HealthEquity logo

About HealthEquity (NASDAQ:HQY) Stock

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.

HQY Stock News Headlines

HealthEquity (NASDAQ:HQY) Releases FY 2023 Earnings Guidance
Is it a Great Time to Invest in HealthEquity (HQY)?
HealthEquity (NASDAQ:HQY) Trading 2.3% Higher
HealthEquity (HQY) Q1 Earnings Miss Estimates
HealthEquity (HQY) Q1 2023 Earnings Call Transcript
See More Headlines

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HQY
Employees
3,695
Year Founded
N/A

Company Calendar

Last Earnings
6/06/2022
Today
7/05/2022
Next Earnings (Estimated)
9/14/2022
Fiscal Year End
1/31/2023

Price Target and Rating

Average Stock Price Forecast
$75.73
High Stock Price Forecast
$95.00
Low Stock Price Forecast
$56.00
Forecasted Upside/Downside
+30.7%
Consensus Rating
Buy
Rating Score (0-4)
3
Research Coverage
10 Analysts

Profitability

Net Income
$-44,290,000.00
Pretax Margin
-10.12%

Debt

Sales & Book Value

Annual Sales
$756.56 million
Cash Flow
$2.52 per share
Book Value
$22.16 per share

Miscellaneous

Free Float
82,006,000
Market Cap
$4.89 billion
Optionable
Optionable
Beta
1.04














HealthEquity Frequently Asked Questions

Should I buy or sell HealthEquity stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last year. There are currently 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HealthEquity stock.
View analyst ratings for HealthEquity
or view top-rated stocks.

What is HealthEquity's stock price forecast for 2022?

10 equities research analysts have issued twelve-month target prices for HealthEquity's stock. Their HQY stock forecasts range from $56.00 to $95.00. On average, they anticipate HealthEquity's stock price to reach $75.73 in the next twelve months. This suggests a possible upside of 30.2% from the stock's current price.
View analysts' price targets for HealthEquity
or view top-rated stocks among Wall Street analysts.

How has HealthEquity's stock performed in 2022?

HealthEquity's stock was trading at $44.24 at the beginning of 2022. Since then, HQY shares have increased by 31.5% and is now trading at $58.18.
View the best growth stocks for 2022 here
.

When is HealthEquity's next earnings date?

HealthEquity is scheduled to release its next quarterly earnings announcement on Wednesday, September 14th 2022.
View our earnings forecast for HealthEquity
.

How were HealthEquity's earnings last quarter?

HealthEquity, Inc. (NASDAQ:HQY) announced its quarterly earnings data on Monday, June, 6th. The company reported $0.15 EPS for the quarter, beating analysts' consensus estimates of $0.11 by $0.04. The firm earned $205.68 million during the quarter, compared to analysts' expectations of $202.72 million. HealthEquity had a negative net margin of 7.11% and a positive trailing twelve-month return on equity of 3.03%. During the same quarter in the previous year, the company earned $0.25 earnings per share.
View HealthEquity's earnings history
.

What guidance has HealthEquity issued on next quarter's earnings?

HealthEquity updated its FY 2023 earnings guidance on Monday, July, 4th. The company provided EPS guidance of $1.23-$1.32 for the period, compared to the consensus estimate of $1.27. The company issued revenue guidance of $827.00 million-$837.00 million, compared to the consensus revenue estimate of $826.16 million.

Who are HealthEquity's key executives?

HealthEquity's management team includes the following people:

What is Jon Kessler's approval rating as HealthEquity's CEO?

197 employees have rated HealthEquity CEO Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among HealthEquity's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of HealthEquity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Square (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP).

What is HealthEquity's stock symbol?

HealthEquity trades on the NASDAQ under the ticker symbol "HQY."

How do I buy shares of HealthEquity?

Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is HealthEquity's stock price today?

One share of HQY stock can currently be purchased for approximately $58.18.

How much money does HealthEquity make?

HealthEquity (NASDAQ:HQY) has a market capitalization of $4.91 billion and generates $756.56 million in revenue each year. The company earns $-44,290,000.00 in net income (profit) each year or ($0.66) on an earnings per share basis.

How many employees does HealthEquity have?

HealthEquity employs 3,695 workers across the globe.

How can I contact HealthEquity?

HealthEquity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The official website for HealthEquity is www.healthequity.com. The company can be reached via phone at (801) 727-1000, via email at rputnam@healthequity.com, or via fax at 801-727-1005.

This page (NASDAQ:HQY) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.